Across TCGA pan-cancer cohorts, RNA activity of the Protein quality control for misfolded or incompletely synthesized proteins pathway is associated with patient survival in 18 of 34 cancer lineages. Pathway activity is summarized from the expression of its 31 member genes.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher Protein quality control for misfolded or incompletely synthesized proteins pathway activity is associated with better overall survival. In most high-consensus cancer types, elevated pathway activity shows an unfavorable survival association, although some cancer types, such as BRCA and UCS, show the opposite pattern, with higher activity associated with better survival.
BRCA, UVM, and LUSC are the cancer lineages in which this pathway most reproducibly stratifies patient survival.
Pathway-activity survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 represent the survival AUCs for the high- and low-pathway-activity groups, respectively. The group with the lower AUC is interpreted as having poorer survival. The reported p-values are derived from the log-rank test.